136 related articles for article (PubMed ID: 26123483)
21. Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition.
Yuen HF; Chan YK; Grills C; McCrudden CM; Gunasekharan V; Shi Z; Wong AS; Lappin TR; Chan KW; Fennell DA; Khoo US; Johnston PG; El-Tanani M
J Pathol; 2011 May; 224(1):78-89. PubMed ID: 21404275
[TBL] [Abstract][Full Text] [Related]
22. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-inducible factor 1 and breast cancer metastasis.
Liu ZJ; Semenza GL; Zhang HF
J Zhejiang Univ Sci B; 2015 Jan; 16(1):32-43. PubMed ID: 25559953
[TBL] [Abstract][Full Text] [Related]
24. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
25. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of a novel platform-independent metastasis signature in human breast cancer.
Zhao SG; Shilkrut M; Speers C; Liu M; Wilder-Romans K; Lawrence TS; Pierce LJ; Feng FY
PLoS One; 2015; 10(5):e0126631. PubMed ID: 25974184
[TBL] [Abstract][Full Text] [Related]
27. A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome.
Stylianou N; Lehman ML; Wang C; Fard AT; Rockstroh A; Fazli L; Jovanovic L; Ward M; Sadowski MC; Kashyap AS; Buttyan R; Gleave ME; Westbrook TF; Williams ED; Gunter JH; Nelson CC; Hollier BG
Oncogene; 2019 Feb; 38(7):913-934. PubMed ID: 30194451
[TBL] [Abstract][Full Text] [Related]
28. Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival.
Gaude E; Frezza C
Nat Commun; 2016 Oct; 7():13041. PubMed ID: 27721378
[TBL] [Abstract][Full Text] [Related]
29. Glucocorticoid receptor: a harmonizer of cellular plasticity in breast cancer-directs the road towards therapy resistance, metastatic progression and recurrence.
Thakur D; Sengupta D; Mahapatra E; Das S; Sarkar R; Mukherjee S
Cancer Metastasis Rev; 2024 Mar; 43(1):481-499. PubMed ID: 38170347
[TBL] [Abstract][Full Text] [Related]
30. Cellular plasticity and metastatic potential.
Bonekey Rep; 2012; 1():139. PubMed ID: 23951519
[No Abstract] [Full Text] [Related]
31. EMT-induced metabolite signature identifies poor clinical outcome.
Bhowmik SK; Ramirez-Peña E; Arnold JM; Putluri V; Sphyris N; Michailidis G; Putluri N; Ambs S; Sreekumar A; Mani SA
Oncotarget; 2015 Dec; 6(40):42651-60. PubMed ID: 26315396
[TBL] [Abstract][Full Text] [Related]
32. Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells.
Cohen EN; Gao H; Anfossi S; Mego M; Reddy NG; Debeb B; Giordano A; Tin S; Wu Q; Garza RJ; Cristofanilli M; Mani SA; Croix DA; Ueno NT; Woodward WA; Luthra R; Krishnamurthy S; Reuben JM
PLoS One; 2015; 10(7):e0132710. PubMed ID: 26207636
[TBL] [Abstract][Full Text] [Related]
33. Coupling the modules of EMT and stemness: A tunable 'stemness window' model.
Jolly MK; Jia D; Boareto M; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
Oncotarget; 2015 Sep; 6(28):25161-74. PubMed ID: 26317796
[TBL] [Abstract][Full Text] [Related]
34. Stabilizing vimentin phosphorylation inhibits stem-like cell properties and metastasis of hybrid epithelial/mesenchymal carcinomas.
Kuburich NA; den Hollander P; Castaneda M; Pietilä M; Tang X; Batra H; Martínez-Peña F; Visal TH; Zhou T; Demestichas BR; Dontula RV; Liu JY; Maddela JJ; Padmanabhan RS; Phi LTH; Rosolen MJ; Sabapathy T; Kumar D; Giancotti FG; Lairson LL; Raso MG; Soundararajan R; Mani SA
Cell Rep; 2023 Dec; 42(12):113470. PubMed ID: 37979166
[TBL] [Abstract][Full Text] [Related]
35. Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer.
Echeverria GV; Cai S; Tu Y; Shao J; Powell E; Redwood AB; Jiang Y; McCoy A; Rinkenbaugh AL; Lau R; Trevarton AJ; Fu C; Gould R; Ravenberg EE; Huo L; Candelaria R; Santiago L; Adrada BE; Lane DL; Rauch GM; Yang WT; White JB; Chang JT; Moulder SL; Symmans WF; Hilsenbeck SG; Piwnica-Worms H
NPJ Breast Cancer; 2023 Jan; 9(1):2. PubMed ID: 36627285
[TBL] [Abstract][Full Text] [Related]
36. CCM signaling complex (CSC) couples both classic and non-classic Progesterone receptor signaling.
Abou-Fadel J; Jiang X; Grajeda B; Padarti A; Ellis CC; Flores E; Cailing-De La O AD; Zhang J
Cell Commun Signal; 2022 Aug; 20(1):120. PubMed ID: 35971177
[TBL] [Abstract][Full Text] [Related]
37. Acetylated HOXB13 Regulated Super Enhancer Genes Define Therapeutic Vulnerabilities of Castration-Resistant Prostate Cancer.
Nguyen DT; Yang W; Renganathan A; Weimholt C; Angappulige DH; Nguyen T; Sprung RW; Andriole GL; Kim EH; Mahajan NP; Mahajan K
Clin Cancer Res; 2022 Sep; 28(18):4131-4145. PubMed ID: 35849143
[TBL] [Abstract][Full Text] [Related]
38. Embryonic Programs in Cancer and Metastasis-Insights From the Mammary Gland.
Lee MY
Front Cell Dev Biol; 2022; 10():938625. PubMed ID: 35846378
[TBL] [Abstract][Full Text] [Related]
39. Transcription Control of Liver Development.
Tachmatzidi EC; Galanopoulou O; Talianidis I
Cells; 2021 Aug; 10(8):. PubMed ID: 34440795
[TBL] [Abstract][Full Text] [Related]
40. Osteoclasts in Tumor Biology: Metastasis and Epithelial-Mesenchymal-Myeloid Transition.
Behzatoglu K
Pathol Oncol Res; 2021; 27():609472. PubMed ID: 34257573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
